{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-112139","form_type":"8-K","ticker":"SRPT","cik":"0000873303","company_name":"Sarepta Therapeutics, Inc.","filed_at":"2022-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.040461+00:00","generated_at":"2026-06-26T05:58:20.762353+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sarepta amends CEO Ingram's stock option; 33% vests immediately; new targets to 2025","bullets":["33.33% (1,099,890 shares) of performance option vested effective April 19, 2022; remainder eligible through June 26, 2025.","Unvested portion triggers at stock prices $105.74, $128.65, $155.37, $186.36, requiring relative CAGR vs Biotech Index.","New one-year holding period on shares acquired upon exercise, except for change in control, death, disability, or certain terminations.","Change-in-control vesting requires minimum $130/share sale price if within 18 months; else next column applies.","Company expects significant non-cash accounting charge for the amendment; to be disclosed in upcoming 10-Q."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-112139","json":"https://secwatch.observer/filing/0001193125-22-112139.json","markdown":"https://secwatch.observer/filing/0001193125-22-112139.md","text":"https://secwatch.observer/filing/0001193125-22-112139.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/873303/000119312522112139/0001193125-22-112139-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/873303/000119312522112139/d329540d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T05:58:20.762353+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}